Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Ford Recalls Nearly 274,000 SUVs In US: Retail Gets More Bearish
Via Stocktwits
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
Tickers F NVDA SCHD VTI
Ford Issues Recall Of Over 270,000 Vehicles As Safety Concerns Mount
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers DRIV F GM IYK
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
Via MarketBeat
Topics Earnings
Exposures Financial Product Safety
Tickers KRYS LNTH SRPT WFC
Waymo Recalls Over 1,200 Robotaxis Over Software Issue: Retail Sentiment Dips On Parent Alphabet
Via Stocktwits
Topics Product Recall
Exposures Legal Product Safety
Tickers GOOG GOOGL UAL VTI
TD Securities Financial Advisor Isabella Gravinese
Via Binary News Network
Topics Artificial Intelligence Economy Retirement
Exposures Artificial Intelligence Interest Rates Pension
Robert Kennedy Jr. Cheers FDA Plan To Ban Fluoride Supplements For Children, Calls Move 'Long Overdue'
Via Benzinga
Exposures Product Safety
Club Cruise™ Reports: Southwest Airlines Ends Open Seating, Adds Bag Fees in Major 2025 Shift
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
Tickers LUV
Telepathic iPhone? Apple Steps Into Elon Musk's Neuralink Territory With Bold Brain-Control Tech
Via Stocktwits
Exposures Product Safety
Tickers AAPL VTI XLK
Discover the Future of Non-Invasive Body Sculpting at Scottsdale Med Spa
Via AB Newswire
Exposures Product Safety
Braden Counseling Center Unveils Deep TMS Therapy in Sycamore, IL
Via Press Advantage
Exposures Product Safety
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Via Get News
Topics Death Economy
Exposures Death Product Safety Supply Chain
Tickers ABT CVKD
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
Via PRLog
Topics Death Economy
Exposures Death Product Safety Supply Chain
Addressing Powdering Issues in PE Film Processing: Constructive Solutions for Enhanced Production
Via AB Newswire
Topics Bonds Product Recall Supply Chain
Exposures Debt Markets Legal Product Safety
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via NewMediaWire
Exposures Product Safety
Tickers ICU
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via TheNewswire.com
Exposures Product Safety
Tickers ICU
Best Biotech Stocks to Buy in 2025
Via MarketBeat
Topics ETFs Economy Government
Exposures COVID-19 Interest Rates Political
Tickers AKRO REGN VRTX XBI
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Via The Motley Fool
Exposures Product Safety
Tickers TMDX
Thomas D'Aguanno Announces the Release of His Debut Novella StarStruck, Tapping into '90s Nostalgia with the Help of AI
Via Press Release Distribution Service
Topics Artificial Intelligence Intellectual Property Product Recall
Exposures Artificial Intelligence Intellectual Property Layoff
Moleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ Setup
Via Stocktwits
Exposures Product Safety
Tickers MBRX
Full-Spectrum Organic CBD Oil For Pets, Pain & Anxiety Relief Formula Announced
Via Press Release Distribution Service
Topics Cannabis
Exposures Cannabis Product Safety
US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events
Via Benzinga
Topics Death
Exposures Death Product Safety
Tickers VALN
Mental Health Awareness Month—Tennessee Enacts Psychotropic Testing Law
Via PRLog
Exposures Product Safety
SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline
Via NewMediaWire
Exposures Product Safety
Tickers ICU
SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline
Via TheNewswire.com
Exposures Product Safety
Tickers ICU
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15
Via Investor Brand Network
Exposures Product Safety
Tickers BMWYY NRXP
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate
Via Investor Brand Network
Exposures Product Safety
Tickers QNTM
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers BMY LTRN
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.